Product logins

Find logins to all Clarivate products below.


Neurostimulation Devices | Market Insights | Europe | 2022

The European neurostimulation device market has been strongly impacted by the COVID-19 pandemic; however, following this impact, it will grow modestly, fueled by the ongoing product innovation to improve treatment efficacy and to address new indications, favorable demographic trends, new competitors entering the market, and ongoing postmarket clinical studies. However, limited reimbursement and the preference for alternative treatments in the neurostimulation device market segments will limit the growth of the overall market.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for neurostimulation devices in France, Germany, Italy, Spain and the UK across an 11-year period.

Related Medtech Insights Reports

Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…
Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…
Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…
Report
Heart Valve Devices – Market Insights – Europe
The European heart valve device market will continue to observe moderate growth, particularly due to growing demand for minimally invasive cardiac interventions boosting the adoption of THV devices…